A prospective multicenter observational study of patients treated with systemic chemotherapy for hepatocellular carcinoma

A prospective multicenter observational study of patients treated with systemic chemotherapy for hepatocellular carcinoma - Systemic chemotherapy for hepatocellular carcinoma: a prospective multicenter observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034611

Enrollment

100

Registered

2018-10-23

Start date

2018-10-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with 20 years of age and older (2) Patients expected to survive for more than 12 weeks (3) Patients diagnosed as typical hepatocellular carcinoma by histological/cytological diagnosis or imaging diagnosis by dynamic CT (or MRI) (4) Patients who are difficult for surgical resection or locoregional therapies and are indicated for systemic chemotherapy (5) Patients with Eastern Cooperative Oncology Group performance status score of 0 or 1 (6) No contraindication to systemic chemotherapy, per the approved package insert of each medication

Exclusion criteria

Exclusion criteria: (1) Patients who do not give informed consent (2) Patients who are not judged to be eligible for participation in this study by researchers

Design outcomes

Primary

Measure	Time frame
Anti-tumor effects and long-term prognosis in patients treated with systemic chemotherapy for hepatocellular carcinoma	—

Countries

Japan

Contacts

Public ContactKazuki Maesaka

Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology

k.maesaka@gh.med.osaka-u.ac.jp06-6879-3621

Outcome results